dactinomycin has been researched along with Myofibromatosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angiolillo, A; Huppmann, A; Meany, H; Navid, F; Weaver, MS | 1 |
| Ardeshirpour, F; Drake, AF; Ebert, CS; Hart, CF; Patel, M; Zdanski, C | 1 |
| Gandhi, MM; Levitt, GA; Nathan, PC; Weitzman, S | 1 |
2 review(s) available for dactinomycin and Myofibromatosis
| Article | Year |
|---|---|
Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Humans; Infant; Infant, Newborn; Male; Myofibromatosis; Prognosis; Vincristine | 2015 |
Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Critical Care; Dactinomycin; Female; Humans; Infant, Newborn; Male; Methotrexate; Muscle Neoplasms; Myofibromatosis; Osteolysis; Prednisolone; Remission Induction; Respiration, Artificial; Skin Neoplasms; Soft Tissue Neoplasms; Vinblastine; Vincristine | 2003 |
1 other study(ies) available for dactinomycin and Myofibromatosis
| Article | Year |
|---|---|
Recurrent infantile myofibromatosis: a report of conservative management and discussion of treatment strategies.
Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Child, Preschool; Cyclophosphamide; Dactinomycin; Humans; Male; Maxillary Neoplasms; Myeloablative Agonists; Myofibromatosis; Remission Induction; Vincristine | 2008 |